We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing
News

Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing

Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing
News

Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing

Ajinomoto OmniChem
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Ajinomoto OmniChem, an innovative provider of small molecule API, contract development and manufacturing services, today announced the successful completion of a commercial scale manufacturing campaign that involved adapting a traditional multi-step batch process into a continuous flow chemistry platform. Continuous flow manufacturing has several advantages over batch production including reduction of overall processing time, increased reaction selectivity, better product quality, saving on temporary storage costs, better control of the entire production process, and safer reactions at high temperatures & pressures when handling hazardous materials. The mobile installation of the continuous flow platform was designed and implemented in OmniChem’s pilot plan facility based in Wetteren, Belgium.

Dr. Eric De Vos, Business Unit and R&D Director of Pharmaceutical Fine Chemicals states: “We have been very eager to implement our continuous flow design and our teams have gained significant knowledge around this platform which will facilitate rapid changeovers and modifications for future client programs. Adopting continuous flow technology is instrumental to OmniChem’s expansion strategy and complements other service offerings including wiped film evaporation, build-out of additional suites for highly potent API and sensitive chemistry, oligopeptide and oligonucleotide manufacturing, micronization, and preparative HPLC.”

The continuous flow capability enables R&D and scale up to 100kg commercial levels and its modular construction allows for easy adaptation to other manufacturing processes. Building out this continuous flow platform is supported by the multi-year grant awards OmniChem received from the Belgian government to expand its processing windows and develop new types of reactors for rapid and selective chemical conversions in collaboration with technology providers.

This article has been republished from materials provided by OmniChem. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement